15 Biggest Mid-Day Gainers For Wednesday

Loading...
Loading...
  • Dextera Surgical Inc DXTR shares climbed 64.1 percent to $1.87.
  • Uranium Resources, Inc. URRE shares surged 58.3 percent to $3.56. Uranium Resources shares have dropped 60.94 percent over the past 52 weeks, while the S&P 500 index has gained 17.95 percent in the same period.
  • MYOS RENS Technology Inc MYOS shares gained 42.3 percent to $1.85. MYOS RENS Technology shares have declined 26.55 percent over the past 52 weeks, while the S&P 500 index has gained 17.95 percent in the same period.
  • Derma Sciences Inc DSCI shares jumped 39 percent to $6.95 after the company agreed to be acquired by Integra Lifesciences Holdings Corp IART for $7.00 per share in cash.
  • Biocept Inc BIOC shares surged 33.7 percent to $2.42 after climbing 77.45 percent on Tuesday.
  • E-compass Acquisition Corp. ECAC shares rose 28 percent to $12.67 after the company announced plans to merge with NYM Holding, Inc.
  • Enphase Energy Inc ENPH gained 19.5 percent to $1.35 after the company reported a $10 million strategic investment from T.J.Rodgers and John Doerr.
  • Kornit Digital Ltd KRNT shares gained 15.4 percent to $16.10 after the company disclosed that it has signed an agreement with Amazon for digital printing technology to help Amazon expand on-demand production for garment decoration.
  • Arrowhead Pharmaceuticals Inc ARWR shares jumped 10.9 percent to $2.24 after climbing 6.88 percent on Tuesday.
  • Merck & Co., Inc. MRK gained 4.7 percent to $62.74 after the company disclosed that it has received the FDA acceptance of supplemental Biologics License Application for KEYTRUDA.
  • Keryx Biopharmaceuticals KERX rose 4.4 percent to $6.47. Citigroup upgraded Keryx Biopharmaceuticals from Sell to Neutral.
  • Williams Partners LP WPZ gained 3.6 percent to $40.01. Wells Fargo upgraded Williams Partners from Market Perform to Outperform.
  • Sangamo Therapeutics Inc SGMO shares rose 3.4 percent to $3.78 after the company disclosed that it has received Orphan Drug designation from the FDA for SB-318.
  • TG Therapeutics Inc TGTX shares gained 2.5 percent to $5.12 after the company disclosed positive MS study data.
  • Achaogen Inc AKAO shares rose 2 percent to $15.76 after Baker Bros Advisors reported a 13.1 percent stake in the company.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: NewsIntraday UpdateMarketsAnalyst RatingsMoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...